Antithrombotic treatment for pregnancy complications: Which path for the journey to precision medicine?

British Journal of Haematology

Volumn 165, Issue 5, 2014, Pages 585-599

  Greer, Ian A ^a   Brenner, Benjamin ^b   Gris, Jean Christophe ^c  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Department of Haematology and Bone Marrow Transplantation Rambam Health Care Campus ^*  (Israel)

^c NÎMES UNIVERSITY HOSPITAL   (France)

Author keywords

Antithrombotic treatment; Pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; COMPLEMENT COMPONENT C5A; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBOMODULIN; FIBRINOLYTIC AGENT;

ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; BIRTH RATE; CONCEPTION; DISEASE ASSOCIATION; DRUG MECHANISM; DRUG SAFETY; HEMOSTASIS; HETEROZYGOSITY; HUMAN; NONHUMAN; PERSONALIZED MEDICINE; PLACENTA DISORDER; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SPONTANEOUS ABORTION; THROMBOPHILIA; THROMBOSIS PREVENTION; ABORTION, HABITUAL; BLOOD; COMPLICATION; FEMALE; PHYSIOLOGY; PLACENTA DISEASES; PREGNANCY; PRENATAL CARE; PROCEDURES;

ABORTION, HABITUAL; FEMALE; FIBRINOLYTIC AGENTS; HEMOSTASIS; HUMANS; INDIVIDUALIZED MEDICINE; PLACENTA DISEASES; PREGNANCY; PRENATAL CARE; THROMBOPHILIA;

EID: 84900518217     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12813     Document Type: Review

References (117)

1. Abou-Nassar, K., Carrier, M., Ramsay, T. & Rodger, M.A. (2011) The association between antiphospholipid antibodies and placenta mediated complications: a systematic review and meta-analysis. Thrombosis Research, 128, 77-85.
2. Aharon, A., Brenner, B., Katz, T., Miyagi, Y. & Lanir, N. (2004) Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental hemostasis. Thrombosis and Haemostasis, 92, 776-786.
3. Aharon, A., Lanir, N., Drugan, A. & Brenner, B. (2005) Placental TFPI is decreased in gestational vascular complications and can be restored by maternal enoxaparin treatment. Journal of Thrombosis and Haemostasis, 3, 2355-2357.
4. Aharon, A., Katzenell, S., Tamari, T. & Brenner, B. (2009) Microparticles bearing tissue factor and tissue factor pathway inhibitor in gestational vascular complications. Journal of Thrombosis and Haemostasis, 7, 1047-1050.
5. Ananth, C.V. & Vintzileos, A.M. (2006) Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth. American Journal of Obstetrics and Gynecology, 195, 1557-1563.
6. Ball, E., Bulmer, J.N., Ayis, S., Lyall, F. & Robson, S.C. (2006) Late sporadic miscarriage is associated with abnormalities in spiral artery transformation and trophoblast invasion. Journal of Pathology, 208, 535-542.
7. Bates, S.M., Greer, I.A., Middeldorp, S., Veenstra, D.L., Prabulos, A.M. & Vandvik, P.O. (2012) VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141(Suppl. 2), e691S-e736S.
8. Bouvier, S., Cochery-Nouvellon, E., Lavigne-Lissalde, G., Mercier, E., Marchetti, T., Balducchi, J.P., Marès, P. & Gris, J.C. (2014) Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study. Blood, 123, 404-413.
9. Brenner, B., Sarig, G., Weiner, Z., Younis, J., Blumenfeld, Z. & Lanir, N. (1999) Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Thrombosis and Haemostasis, 82, 6-9.
10. Brenner, B., Hoffman, R., Blumenfeld, Z., Weiner, Z. & Younis, J.S. (2000) Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thrombosis and Haemostasis, 83, 693-697.
11. Brenner, B., Hoffman, R., Carp, H., Dulitsky, M. & Younis, J. (2005a) Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. Journal of Thrombosis and Haemostasis, 3, 227-229.
12. Brenner, B., Bar, J., Ellis, M., Yarom, I., Yohai, D. & Samueloff, A. (2005b) Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox study. Fertility and Sterility, 84, 770-773.
13. Bujold, E., Roberge, S., Lacasse, Y., Bureau, M., Audibert, F., Marcoux, S., Forest, J.C. & Giguère, Y. (2010) Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstetrics and Gynecology, 116, 402-414.
14. Carp, H., Dolitzky, M. & Inbal, A. (2003) Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia. Journal of Thrombosis and Haemostasis, 1, 433-438.
15. Carroll, T.Y., Mulla, M.J., Han, C.S., Brosens, J.J., Chamley, L.W., Giles, I., Pericleous, C., Rahman, A., Sfakianaki, A.K., Paidas, M.J. & Abrahams, V.M. (2011) Modulation of trophoblast angiogenic factor secretion by antiphospholipid antibodies is not reversed by heparin. American Journal of Reproductive Immunology, 66, 286-296.
16. Cha, J., Sun, X. & Dey, S.K. (2012) Mechanisms of implantation: strategies for successful pregnancy. Nature Medicine, 18, 1754-1767.
17. Chinni, E., Tiscia, G.L., Colaizzo, D., Vergura, P., Margaglione, M. & Grandone, E. (2009) Annexin V expression in human placenta is influenced by the carriership of the common haplotype M2. Fertility and Sterility, 91, 940-942.
18. Clark, P., Walker, I.D., Langhorne, P., Crichton, L., Thomson, A., Greaves, M., Whyte, S., Greer, I.A. & Scottish Pregnancy Intervention Study (SPIN) collaborators. (2010) SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. Blood, 115, 4162-4167.
19. D'Ippolito, S., Marana, R., Di Nicuolo, F., Castellani, R., Veglia, M., Stinson, J., Scambia, G. & Di Simone, N. (2012) Effect of Low Molecular Weight Heparins (LMWHs) on antiphospholipid Antibodies (aPL)-mediated inhibition of endometrial angiogenesis. PLoS ONE, 7, e29660.
20. Dodd, J.M., McLeod, A., Windrim, R.C. & Kingdom, J. (2013) Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. The Cochrane Database of Systematic Reviews, (7), Art. No.: CD006780. DOI: 10.1002/14651858.CD006780.pub3
21. Drewlo, S., Levytska, K., Sobel, M., Baczyk, D., Lye, S.J. & Kingdom, J.C. (2011) Heparin promotes soluble VEGF receptor expression in human placental villi to impair endothelial VEGF signaling. Journal of Thrombosis and Haemostasis, 9, 2486-2497.
22. Duley, L., Henderson-Smart, D.J., Meher, S. & King, J.F. (2007) Antiplatelet agents for preventing pre-eclampsia and its complications. The Cochrane Database of Systematic Reviews, (2), Art. No.: CD004659. DOI: 10.1002/14651858.CD004659.pub2
23. Edstrom, C.S., Calhoun, D.A. & Christensen, R.D. (2000) Expression of tissue factor pathway inhibitor in human fetal and placental tissues. Early Human Development, 59, 77-84.
24. Empson, M., Lassere, M., Craig, J. & Scott, J. (2005) Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. The Cochrane Database of Systematic Reviews, (2), Art. No.: CD002859. DOI: 10.1002/14651858.CD002859.pub2
25. Farquharson, R.G., Quenby, S. & Greaves, M. (2002) Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstetrics and Gynecology, 100, 408-413.
26. Ferrazzi, E. & Gris, J.C. (2012) The evidence of the HAPPY trial is severely limited by the criteria and the methodology of recruitment. Blood. e-Letter, June 1, http://bloodjournal.hematologylibrary.org/letters?first-index=21&hits=10.
27. Fisher, S.J. (2004) The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia. Reproductive Biology and Endocrinology, 2, 53.
28. Folkeringa, N., Brouwer, J.L., Korteweg, F.J., Veeger, N.J., Erwich, J.J., Holm, J.P. & van der Meer, J. (2007) Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women. British Journal of Haematology, 136, 656-661.
29. Germain, S.J., Sacks, G.P., Sooranna, S.R., Sargent, I.L. & Redman, C.W. (2007) Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. Journal of Immunology, 178, 5949-5956.
30. Girardi, G., Berman, J., Redecha, P., Spruce, L., Thurman, J.M., Kraus, D., Hollmann, T.J., Casali, P., Caroll, M.C., Wetsel, R.A., Lambris, J.D., Holers, V.M. & Salmon, J.E. (2003) Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. The Journal of Clinical Investigation, 112, 1644-1654.
31. Goel, N., Tuli, A. & Choudhry, R. (2006) The role of aspirin versus aspirin and heparin in cases of recurrent abortions with raised anticardiolipin antibodies. Medical Science Monitor, 12, CR132-CR136.
32. Goswami, D., Tannetta, D.S., Magee, L.A., Fuchisawa, A., Redman, C.W., Sargent, I.L. & von Dadelszen, P. (2006) Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta, 27, 56-61.
33. Greer, I.A. (2009) Low molecular weight heparin for pregnancy complications? Thrombosis Research, 123(Suppl. 3), S22-S25.
34. Greer, I.A. & Nelson-Piercy, C. (2005) Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood, 106, 401-407.
35. Gris, J.C. (2009) Thrombophilia and pregnancy loss: cause or association. Thrombosis Research, 123(Suppl. 2), S105-S110.
36. Gris, J.C., Quéré, I., Monpeyroux, F., Mercier, E., Ripart-Neveu, S., Tailland, M.L., Hoffet, M., Berlan, J., Daurès, J.P. & Marès, P. (1999) Case-control study of the frequency of thrombophilic disorders in couples with late fetal loss and no thrombotic antecedent-the Nimes Obstetricians and Haematologists Study5 (NOHA5). Thrombosis and Haemostasis, 81, 891-899.
37. Gris, J.C., Mercier, E., Quéré, I., Lavigne-Lissalde, G., Cochery-Nouvellon, E., Hoffet, M., Ripart-Neveu, S., Tailland, M.L., Dauzat, M. & Marès, P. (2004) Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood, 103, 3695-3699.
38. Gris, J.C., Chauleur, C., Faillie, J.L., Baer, G., Mares, P., Fabbro-Peray, P., Quéré, I., Lefrant, J.Y., Haddad, B. & Dauzat, M. (2010) Enoxaparin for the secondary prevention of placental vascular complications in women with abruptio placentae. The pilot randomised controlled NOH-AP trial. Thrombosis and Haemostasis, 104, 771-779.
39. Gris, J.C., Chauleur, C., Molinari, N., Mares, P., Fabbro-Peray, P., Quéré, I., Lefrant, J.Y., Haddad, B. & Dauzat, M. (2011) Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia. The pilot randomised controlled NOH-PE trial. Thrombosis and Haemostasis, 106, 1053-1061.
40. Gu, J.M., Crawley, J.T., Ferrell, G., Zhang, F., Li, W., Esmon, N.L. & Esmon, C.T. (2002) Disruption of the endothelial cell protein C receptor gene in mice causes placental thrombosis and early embryonic lethality. Journal of Biological Chemistry, 277, 43335-43343.
41. Han, C.S., Mulla, M.J., Brosens, J.J., Chamley, L.W., Paidas, M.J., Lockwood, C.J. & Abrahams, V.M. (2011) Aspirin and heparin effect on basal and antiphospholipid antibody modulation of trophoblast function. Obstetrics and Gynecology, 118, 1021-1028.
42. Hempstock, J., Jauniaux, E., Greenwold, N. & Burton, G.J. (2003) The contribution of placental oxidative stress to early pregnancy failure. Human Pathology, 34, 1265-1275.
43. Hiltunen, L.M., Laivuori, H., Rautanen, A., Kaaja, R., Kere, J., Krusius, T., Paunio, M. & Rasi, V. (2010) Factor V Leiden as risk factor for unexplained stillbirth-a population-based nested case-control study. Thrombosis Research, 125, 505-510.
44. Hiltunen, L.M., Laivuori, H., Rautanen, A., Kaaja, R., Kere, J., Krusius, T., Rasi, V. & Paunio, M. (2011) Factor V Leiden as a risk factor for preterm birth -a population-based nested case-control study. Journal of Thrombosis and Haemostasis, 9, 71-78.
45. Hirsh, J. & Levine, M.N. (1992) Low molecular weight heparin. Blood, 79, 1-17.
46. Hu, Z.Y., Liu, Y.X., Liu, K., Byrne, S., Ny, T., Feng, Q. & Ockleford, C.D. (1999) Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta. Journal of Anatomy, 194, 183-195.
47. Hube, F., Reverdiau, P., Lochmann, S., Trassard, S., Thibault, G. & Gruel, Y. (2003) Demonstration of a tissue factor pathway inhibitor 2 messenger RNA synthesis by pure villous cytotrophoblast cells isolated from term human placentas. Biology of Reproduction, 68, 1888-1894.
48. Huissoud, C., Carrabin, N., Benchaib, M., Fontaine, O., Levrat, A., Massignon, D., Touzet, S., Rudigoz, R.C. & Berland, M. (2009) Coagulation assessment by rotation thrombelastometry in normal pregnancy. Thrombosis and Haemostasis, 101, 755-761.
49. Hung, T.H., Charnock-Jones, D.S., Skepper, J.N. & Burton, G.J. (2004) Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. American Journal of Pathology, 164, 1049-1061.
50. Isermann, B., Sood, R., Pawlinski, R., Zogg, M., Kalloway, S., Degen, J.L., Mackman, N. & Weiler, H. (2003) The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nature Medicine, 9, 331-337.
51. Kaandorp, S.P., Goddijn, M., van der Post, J.A., Hutten, B.A., Verhoeve, H.R., Hamulyak, K., Mol, B.W., Folkeringa, N., Nahuis, M., Papatsonis, D.N., Büller, H.R., van der Veen, F. & Middeldorp, S. (2010) Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. New England Journal of Medicine, 362, 1586-1596.
52. Katzenell, S., Shomer, E., Zipori, Y., Zylberfisz, A., Brenner, B. & Aharon, A. (2012) Characterization of negatively charged phospholipids and cell origin of microparticles in women with gestational vascular complications. Thrombosis Research, 130, 479-484.
53. Keeling, D., Mackie, I., Moore, G.W., Greer, I.A., Greaves, M. & British Committee for Standards in Haematology. (2012) Guidelines on the investigation and management of antiphospholipid syndrome. British Journal of Haematology, 157, 47-58.
54. Knol, H.M., Kemperman, R.F., Kluin-Nelemans, H.C., Mulder, A.B. & Meijer, K. (2012) Haemostatic variables during normal menstrual cycle. A systematic review. Thrombosis and Haemostasis, 107, 22-29.
55. Kutteh, W.H. (1996) Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. American Journal of Obstetrics and Gynecology, 174, 1584-1589.
56. Laskin, C.A., Spitzer, K.A., Clark, C.A., Crowther, M.R., Ginsberg, J.S., Hawker, G.A., Kingdom, J.C., Barrett, J. & Gent, M. (2009) Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. Journal of Rheumatology, 36, 279-287.
57. Lessey, B.A. (2011) Assessment of endometrial receptivity. Fertility and Sterility, 96, 522-529.
58. Li, W., Zheng, X., Gu, J.M., Ferrell, G.L., Brady, M., Esmon, N.L. & Esmon, C.T. (2005) Extraembryonic expression of EPCR is essential for embryonic viability. Blood, 106, 2716-2722.
59. Lindqvist, P.G., Svensson, P.J., Marsaal, K., Grennert, L., Luterkort, M. & Dahlback, B. (1999) Activated protein C resistance (FV:Q506) and pregnancy. Thrombosis and Haemostasis, 81, 532-537.
60. Lissalde-Lavigne, G., Fabbro-Peray, P., Cochery-Nouvellon, E., Mercier, E., Ripart-Neveu, S., Balducchi, J.P., Daurès, J.P., Perneger, T., Quéré, I., Dauzat, M., Marès, P. & Gris, J.C. (2005) Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case-control 'NOHA first' study. Journal of Thrombosis and Haemostasis, 3, 2178-2184.
61. Lockwood, C.J., Krikun, G., Rahman, M., Caze, R., Buchwalder, L. & Schatz, F. (2007) The role of decidualization in regulating endometrial hemostasis during the menstrual cycle, gestation, and in pathological states. Seminars in Thrombosis and Hemostasis, 33, 111-117.
62. Lockwood, C.J., Murk, W., Kayisli, U.A., Buchwalder, L.F., Huang, S.T., Funai, E.F., Krikun, G. & Schatz, F. (2009) Progestin and thrombin regulate tissue factor expression in human term decidual cells. Journal of Clinical Endocrinology and Metabolism, 94, 2164-2170.
63. Lodigiani, C., Di Micco, P., Ferrazzi, P., Libre, L., Arfuso, V., Polatti, F., Lodigiani, C., Di Micco, P., Ferrazzi, P., Libre, L., Arfuso, V., Polatti, F., Lodigiani, C., Di Micco, P., Ferrazzi, P., Libre, L., Arfuso, V., Polatti, F., Lodigiani, C., Di Micco, P., Ferrazzi, P., Libre, L., Arfuso, V., Polatti, F., Lodigiani, C., Di Micco, P., Ferrazzi, P., Libre, L., Arfuso, V., Polatti, F., Lodigiani, C., Di Micco, P., Ferrazzi, P., Libre, L., Arfuso, V., Polatti, F., Lodigiani, C., Di Micco, P., Ferrazzi, P., Libre, L., Arfuso, V., Polatti, F. & Setti, P.E. (2011) Low-molecular-weight heparin in women with repeated implantation failure. Women's Health (London, England), 7, 425-431.
64. Lykke, J.A., Bare, L.A., Olsen, J., Lagier, R., Arellano, A.R., Tong, C., Paidas, M.J. & Langhoff-Roos, J. (2012) Thrombophilias and adverse pregnancy outcomes: results from the Danish National Birth Cohort. Journal of Thrombosis and Haemostasis, 10, 1320-1325.
65. Martinelli, I., Taioli, E., Cetin, I., Marinoni, A., Gerosa, S., Villa, M.V., Bozzo, M. & Mannucci, P.M. (2000) Mutations in coagulation factors in women with unexplained late fetal loss. New England Journal of Medicine, 343, 1015-1018.
66. Martinelli, I., Ruggenenti, P., Cetin, I., Pardi, G., Perna, A., Vergani, P., Acaia, B., Facchinetti, F., La Sala, G.B., Bozzo, M., Rampello, S., Marozio, L., Diadei, O., Gherardi, G., Carminati, S., Remuzzi, G., Mannucci, P.M. & HAPPY Study Group. (2012) Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial. Blood, 119, 3269-3275.
67. McLean, K.C., Bernstein, I.M. & Brummel-Ziedins, K.E. (2012) Tissue factor-dependent thrombin generation across pregnancy. American Journal of Obstetrics and Gynecology, 207, e1-e6.
68. Meinardi, J.R., Middeldorp, S., de Kam, P.J., Koopman, M.M., van Pampus, E.C., Hamulyak, K., Prins, M.H., Büller, H.R. & van der Meer, J. (1999) Increased risk for fetal loss in carriers of the factor V Leiden mutation. Annals of Internal Medicine, 130, 736-739.
69. Mello, G., Parretti, E., Fatini, C., Riviello, C., Gensini, F., Marchionni, M., Mello, G., Parretti, E., Fatini, C., Riviello, C., Gensini, F., Marchionni, M., Mello, G., Parretti, E., Fatini, C., Riviello, C., Gensini, F., Marchionni, M., Mello, G., Parretti, E., Fatini, C., Riviello, C., Gensini, F., Marchionni, M. & Abbate, R. (2005) Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension, 45, 86-91.
70. Miyakis, S., Lockshin, M.D., Atsumi, T., Branch, D.W., Brey, R.L., Cervera, R., Derksen, R.H., De Groot, P.G., Koike, T., Meroni, P.L., Reber, G., Shoenfeld, Y., Tincani, A., Vlachoyiannopoulos, P.G. & Krilis, S.A. (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis, 4, 295-306.
71. Nadir, Y., Brenner, B., Gingis-Velitski, S., Levy-Adam, F., Ilan, N., Zcharia, E., Nadir, E. & Vlodavsky, I. (2008) Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells. Thrombosis and Haemostasis, 99, 133-141.
72. Nadir, Y., Kenig, Y., Drugan, A., Zcharia, E. & Brenner, B. (2010) Involvement of heparanase in vaginal and cesarean section deliveries. Thrombosis Research, 126, e444-e450.
73. Nelson, S.M. & Greer, I.A. (2008) The potential role of heparin in assisted conception. Human Reproduction Update, 14, 623-645.
74. Nelson-Piercy, C., Powrie, R., Borg, J.Y., Rodger, M., Talbot, D.J., Stinson, J. & Greer, I.A. (2011) Tinzaparin use in pregnancy: an international study of the safety and efficacy profile. European Journal of Obstetrics, Gynecology and Reproductive Biology, 159, 293-299.
75. Norwitz, E.R., Schust, D.J. & Fisher, S.J. (2001) Implantation and the survival of early pregnancy. New England Journal of Medicine, 345, 1400-1408.
76. Nurk, E., Tell, G.S., Refsum, H., Ueland, P.M. & Vollset, S.E. (2006) Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine Study. Quarterly Journal of Medicine, 99, 289-298.
77. Ogge, G., Chaiworapongsa, T., Romero, R., Hussein, Y., Kusanovic, J.P., Yeo, L., Kim, C.J. & Hassan, S.S. (2011) Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia. Journal of Perinatal Medicine, 39, 641-652.
78. Opatrny, L., David, M., Kahn, S.R., Shrier, I. & Rey, E. (2006) Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis. Journal of Rheumatology, 33, 2214-2221.
79. Parry, G.C., Erlich, J.H., Carmeliet, P., Luther, T. & Mackman, N. (1998) Low levels of tissue factor are compatible with development and hemostasis in mice. The Journal of Clinical Investigation, 101, 560-569.
80. Pasquier, E., Bohec, C., Mottier, D., Jaffuel, S., Mercier, B., Férec, C., Collet, M. & De Saint Martin, L. (2009) Inherited thrombophilias and unexplained pregnancy loss: an incident case-control study. Journal of Thrombosis and Haemostasis, 7, 306-311.
81. Paternoster, D.M., Stella, A., Simioni, P., Girolami, A. & Snijders, D. (2002) Activated protein C resistance in normal and pre-eclamptic pregnancies. Gynecologic and Obstetric Investigation, 54, 145-149.
82. Preston, F.E., Rosendaal, F.R., Walker, I.D., Briet, E., Berntorp, E., Conard, J., Fontcuberta, J., Makris, M., Mariani, G., Noteboom, W., Pabinger, I., Legnani, C., Scharrer, I., Schulman, S. & van der Meer, F.J. (1996) Increased fetal loss in women with heritable thrombophilia. Lancet, 348, 913-916.
83. Qublan, H., Amarin, Z., Dabbas, M., Farraj, A.E., Beni-Merei, Z., Al-Akash, H., Bdoor, A.N., Nawasreh, M., Malkawi, S., Diab, F., Al-Ahmad, N., Balawneh, M. & Abu-Salim, A. (2008) Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial. Human Fertility (Cambridge), 11, 246-253.
84. Rai, R. & Regan, L. (2006) Recurrent miscarriage. Lancet, 368, 601-611.
85. Rai, R., Cohen, H., Dave, M. & Regan, L. (1997) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). British medical Journal, 314, 253-257.
86. Rai, R., Shlebak, A., Cohen, H., Backos, M., Holmes, Z., Marriott, K. & Regan, L. (2001) Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Human Reproduction, 16, 961-965.
87. Redecha, P., Tilley, R., Tencati, M., Salmon, J.E., Kirchhofer, D., Mackman, N. & Girardi, G. (2007) Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury. Blood, 110, 2423-2431.
88. Redecha, P., van Rooijen, N., Torry, D. & Girardi, G. (2009) Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury. Blood, 113, 4101-4109.
89. Rey, E. & Rivard, G.E. (2011) Is testing for aspirin response worthwhile in high-risk pregnancy? European Journal of Obstetrics, Gynecology, and Reproductive Biology, 157, 38-42.
90. Rey, E., Garneau, P., David, M., Gauthier, R., Leduc, L., Michon, N., Morin, F., Demers, C., Kahn, S.R., Magee, L.A. & Rodger, M. (2009) Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. Journal of Thrombosis and Haemostasis, 7, 58-64.
91. Robb, A.O., Din, J.N., Mills, N.L., Smith, I.B., Blomberg, A., Zikry, M.N., Raftis, J.B., Newby, D.E. & Denison, F.C. (2010) The influence of the menstrual cycle, normal pregnancy and pre-eclampsia on platelet activation. Thrombosis and Haemostasis, 103, 372-378.
92. Roberge, S., Giguere, Y., Villa, P., Nicolaides, K., Vainio, M., Forest, J.C., von Dadelzen, P., Vaiman, D., Tapp, S. & Bujold, E. (2012a) Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis. American Journal of Perinatology, 29, 551-556.
93. Roberge, S., Villa, P., Nicolaides, K., Giguere, Y., Vainio, M., Bakthi, A., Ebrashy, A. & Bujold, E. (2012b) Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagnosis and Therapy, 31, 141-146.
94. Robertson, L., Wu, O., Langhorne, P., Twaddle, S., Clark, P., Lowe, G.D., Walker, I.D., Greaves, M., Brenkel, I., Regan, L., Greer, I.A. & Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. (2006) Thrombophilia in pregnancy: a systematic review. British Journal of Haematology, 132, 171-196.
95. Rodger, M.A., Betancourt, M.T., Clark, P., Lindqvist, P.G., Dizon-Townson, D., Said, J., Seligsohn, U., Carrier, M., Salomon, O. & Greer, I.A. (2010) The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies. PLoS Medicine, 7, e1000292.
96. Roque, H., Paidas, M.J., Funai, E.F., Kuczynski, E. & Lockwood, C.J. (2004) Maternal thrombophilias are not associated with early pregnancy loss. Thrombosis and Haemostasis, 91, 290-295.
97. Ruffatti, A., Tonello, M., Del Ross, T., Cavazzana, A., Grava, C., Noventa, F., Tona, F., Iliceto, S. & Pengo, V. (2006) Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thrombosis and Haemostasis, 96, 337-341.
98. Ruffatti, A., Tonello, M., Cavazzana, A., Bagatella, P. & Pengo, V. (2009) Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy. Thrombosis Research, 123, 482-487.
99. Ruffatti, A., Tonello, M., Visentin, M.S., Bontadi, A., Hoxha, A., De Carolis, S., Botta, A., Salvi, S., Nuzzo, M., Rovere-Querini, P., Canti, V., Mosca, M., Mitic, G., Bertero, M.T., Pengo, V., Boffa, M.C. & Tincani, A. (2011) Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study. Rheumatology (Oxford), 50, 1684-1689.
100. Sailer, T., Zoghlami, C., Kurz, C., Rumpold, H., Quehenberger, P. & Pabinger, I. (2006) Anti-beta2-glycoprotein I antibodies are associated with pregnancy loss in women with the lupus anticoagulant. Thrombosis and Haemostasis, 95, 796-801.
101. Salmon, J.E., Girardi, G. & Holers, V.M. (2003) Activation of complement mediates antiphospholipid antibody-induced pregnancy loss. Lupus, 12, 535.
102. Sanson, B.J., Friederich, P.W., Simioni, P., Zanardi, S., Hilsman, M.V., Girolami, A., ten Cate, J.W. & Prins, M.H. (1996) The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women. Thrombosis and Haemostasis, 75, 387-388.
103. Sarig, G., Blumenfeld, Z., Leiba, R., Lanir, N. & Brenner, B. (2005) Modulation of systemic hemostatic parameters by enoxaparin during gestation in women with thrombophilia and pregnancy loss. Thrombosis and Haemostasis, 94, 980-985.
104. Shamonki, J.M., Salmon, J.E., Hyjek, E. & Baergen, R.N. (2007) Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies. American Journal of Obstetrics and Gynecology, 196, 167.e1-167.e5.
105. Shomer, E., Katzenell, S., Zipori, Y., Sammour, R.N., Isermann, B., Brenner, B. & Aharon, A. (2013) Microvesicles of women with gestational hypertension and preeclampsia affect human trophoblast fate and endothelial function. Hypertension, 62, 893-898.
106. Sifakis, S., Soufla, G., Koukoura, O., Soulitzis, N., Koutroulakis, D., Maiz, N., Konstantinidou, A., Melissari, E. & Spandidos, D.A. (2010) Decreased annexin A5 mRNA placental expression in pregnancies complicated by fetal growth restriction. Thrombosis Research, 125, 326-331.
107. Sood, R., Zogg, M., Westrick, R.J., Guo, Y.H., Kerschen, E.J., Girardi, G., Salmon, J.E., Coughlin, S.R. & Weiler, H. (2007) Fetal gene defects precipitate platelet-mediated pregnancy failure in factor V Leiden mothers. Journal of Experimental Medicine, 204, 1049-1056.
108. Szecsi, P.B., Jorgensen, M., Klajnbard, A., Andersen, M.R., Colov, N.P. & Stender, S. (2010) Haemostatic reference intervals in pregnancy. Thrombosis and Haemostasis, 103, 718-727.
109. Tormene, D., Grandone, E., De Stefano, V., Tosetto, A., Palareti, G., Margaglione, M., Castaman, G., Rossi, E., Ciminello, A., Valdrè, L., Legnani, C., Tiscia, G.L., Bafunno, V., Carraro, S., Rodeghiero, F. & Simioni, P. (2012) Obstetric complications and pregnancy-related venous thromboembolism: the effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation. Thrombosis and Haemostasis, 107, 477-484.
110. Udagawa, K., Yasumitsu, H., Esaki, M., Sawada, H., Nagashima, Y., Aoki, I., Jin, M., Miyagi, E., Nakazawa, T., Hirahara, F., Miyazaki, K. & Miyagi, Y. (2002) Subcellular localization of PP5/TFPI-2 in human placenta: a possible role of PP5/TFPI-2 as an anti-coagulant on the surface of syncytiotrophoblasts. Placenta, 23, 145-153.
111. Visser, J., Ulander, V.M., Helmerhorst, F.M., Lampinen, K., Morin-Papunen, L., Bloemenkamp, K.W. & Kaaja, R.J. (2011) Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial. Thrombosis and Haemostasis, 105, 295-301.
112. van Vliet, H.A., Rodrigues, S.P., Snieders, M.N., van der Meer, F.J., Frolich, M., Rosendaal, F.R., Rosing, J. & Helmerhorst, F.M. (2008) Sensitivity to activated protein C during the menstrual cycle in women with and without factor V Leiden. Thrombosis Research, 121, 757-761.
113. Vossen, C.Y., Preston, F.E., Conard, J., Fontcuberta, J., Makris, M., van der Meer, F.J., Pabinger, I., Palareti, G., Scharrer, I., Souto, J.C., Svensson, P., Walker, I.D. & Rosendaal, F.R. (2004) Hereditary thrombophilia and fetal loss: a prospective follow-up study. Journal of Thrombosis and Haemostasis, 2, 592-596.
114. de Vries, J.I., van Pampus, M.G., Hague, W.M., Bezemer, P.D. & Joosten, J.H. (2012) Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT. Journal of Thrombosis and Haemostasis, 10, 64-72.
115. Wienhard, J., Bielska, B., Munstedt, K., Lang, U. & Zygmunt, M. (2002) Increased endothelial thrombomodulin (TM) expression in pregnancies complicated by IUGR. Journal of Perinatal Medicine, 30, 322-328.
116. Wilcox, A.J., Weinberg, C.R., O'Connor, J.F., Baird, D.D., Schlatterer, J.P., Canfield, R.E., Armstrong, E.G. & Nisula, B.C. (1988) Incidence of early loss of pregnancy. New England Journal of Medicine, 319, 189-194.
117. Zdoukopoulos, N. & Zintzaras, E. (2008) Genetic risk factors for placental abruption: a HuGE review and meta-analysis. Epidemiology, 19, 309-323.